-
1.发明公开COMPOSITIONS COMPRISING MULTIVALENT SYNTHETIC LIGANDS OF SURFACE NUCLEOLIN AND GLYCOSAMINOGLYCANS 审中-公开成分多含VALENTE面及核仁粘多糖合成配体
公开(公告)号：EP2624848A2
公开(公告)日：2013-08-14
申请号：EP11764210.8
申请日：2011-10-04
申请人： Centre National de la Recherche Scientifique CNRS , Elro Pharma , Universite Paris 12 - Val De Marne
发明人： ZIMMER, Robert , COURTY, José
IPC分类号： A61K38/00
CPC分类号： C07K7/08 , A61K31/7068 , A61K31/726 , A61K31/727 , A61K36/00 , A61K36/02 , A61K36/10 , A61K38/06 , A61K38/16 , Y02A50/478 , Y02A50/481 , A61K2300/00
摘要： The present invention relates to a composition comprising a Nucant multivalent synthetic compound and a glycosaminoglycan, the admixture of both compounds forming microspheres comprising both compounds, as well as their use for the treatment or prevention of diseases associated with deregulation of proliferation and/or angiogenesis, such as cancer, inflammatory disease, or for promoting wound healing.
-
公开(公告)号：EP3390661A1
公开(公告)日：2018-10-24
申请号：EP16822642.1
申请日：2016-12-16
申请人： Sorbonne Universite , Centre National de la Recherche Scientifique , Université Pierre et Marie Curie (Paris 6) , Institut National de la Santé et de la Recherche Médicale , Assistance Publique - Hôpitaux de Paris , Universite Paris 12 - Val De Marne
IPC分类号： C12Q1/68
CPC分类号： C12Q1/6886 , C12Q2600/16 , C12Q2600/178
摘要： The present invention provides three new antisense long non coding RNAs (lncRNAs) that allow to diagnose prostate cancer much more accurately than the existent non-invasive diagnostic tools. So, this invention relates to the use of at least one of these antisense 1ncRNA or a combination thereof as a diagnosis marker for prostate cancer. It also relates to an in vitro method for prostate cancer diagnosis of a subject as well as to a kit for performing this method.
-
公开(公告)号：EP2635705A1
公开(公告)日：2013-09-11
申请号：EP11799751.0
申请日：2011-11-03
IPC分类号： C12Q1/68
CPC分类号： C12Q1/6886 , C12Q2600/154 , C12Q2600/16
摘要： The invention relates to a method of screening for colorectal cancer in an individual, comprising a step of measuring the degree of methylation of at least one of the genes selected from NPY and PENK, and fragments or variants thereof, in a biological sample obtained from said individual.
-
公开(公告)号：EP2635705B1
公开(公告)日：2015-08-05
申请号：EP11799751.0
申请日：2011-11-03
IPC分类号： C12Q1/68
CPC分类号： C12Q1/6886 , C12Q2600/154 , C12Q2600/16
-
公开(公告)号：EP2624849A2
公开(公告)日：2013-08-14
申请号：EP11764211.6
申请日：2011-10-04
申请人： Centre National de la Recherche Scientifique (C.N.R.S.) , Universite Paris 12 - Val De Marne , Elro Pharma
发明人： ZIMMER, Robert , COURTY, José
IPC分类号： A61K38/00
CPC分类号： C07K7/08 , A61K31/7068 , A61K31/726 , A61K31/727 , A61K36/00 , A61K36/02 , A61K36/10 , A61K38/06 , A61K38/16 , Y02A50/478 , Y02A50/481 , A61K2300/00
摘要： The present invention relates to a composition comprising a Nucant multivalent synthetic compound and a glycosaminoglycan, the admixture of both compounds forming microspheres comprising both compounds, as well as their use for the treatment or prevention of diseases associated with deregulation of proliferation and/or angiogenesis, such as cancer, inflammatory disease, or for promoting wound healing.
-
-
-
-
搜索结果
5 条记录 (耗时 0.012 秒)
